Dr. Fry

Dr Frye is a Harvard trained Child Neurologist with expertise in neurodevelopmental and

neurometabolic disorders. He received an MD and PhD in Physiology and Biophysics from

Georgetown University. He completed a residency in Pediatrics at the University of Miami,

Residency in Child Neurology and Fellowship in Behavioral Neurology and Learning Disabilities

at Harvard University/Children’s Hospital Boston and Fellowship in Psychology at Boston

University. He also received a Masters in Biomedical Science and Biostatistics from Drexel

University. He holds board certifications in Pediatrics, and in Neurology with Special

Competence in Child Neurology. He has authored over 300 publications and book chapters and

serves on several editorial boards.

Dr. Frye is a national leader in autism spectrum disorder (ASD) research, particularly metabolic

disorders, and has authored over 300 publications. He has developed the Metabolic Learning

Resource which has recently released The Folate Fix. He is President and Chief Scientific

Officer of the Autism Discovery and Treatment Foundation, Chief Medical Officer of the

Neurological Health Foundation, Director of Research and Neurologist at the Rossignol Medical

Center.

He has lead several clinical studies on children with ASD, including studies focusing on defining

the clinical, behavioral, cognitive, genetic and metabolic characteristics of children with ASD and

mitochondrial disease and several clinical trials demonstrating the efficacy of safe and novel

treatments that target underlying physiological abnormalities in children with ASD, including

studies on leucovorin, cobalamin and tetrahydrobiopterin and has an ongoing multicenter

controlled clinical trial on leucovorin, neuroimmune modulators and photobiomodulation.